Although adiponectin as a treatment has not been tested so far in animal models for MS, adiponectin knock-out (KO) mice showed exacerbated behavioral disability and increased inflammatory cell infiltration and demyelination in the CNS. This evidence concerns the gene ADIPOQ and myeloid sarcoma.